BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35910786)

  • 1. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.
    Wang X; Han M; Wang S; Sun Y; Zhao W; Xue Z; Liang X; Huang B; Li G; Chen A; Li X; Wang J
    Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
    [No Abstract]   [Full Text] [Related]  

  • 2. TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO.
    Chen Y; Xu X; Ding K; Tang T; Cai F; Zhang H; Chen Z; Qi Y; Fu Z; Zhu G; Dou Z; Xu J; Chen G; Wu Q; Ji J; Zhang J
    J Exp Clin Cancer Res; 2024 Feb; 43(1):39. PubMed ID: 38303029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity.
    Kim JH; Jeong K; Li J; Murphy JM; Vukadin L; Stone JK; Richard A; Tran J; Gillespie GY; Flemington EK; Sobol RW; Lim SS; Ahn EE
    Nat Commun; 2021 Sep; 12(1):5551. PubMed ID: 34548489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NONO and tumorigenesis: More than splicing.
    Feng P; Li L; Deng T; Liu Y; Ling N; Qiu S; Zhang L; Peng B; Xiong W; Cao L; Zhang L; Ye M
    J Cell Mol Med; 2020 Apr; 24(8):4368-4376. PubMed ID: 32168434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR.
    Xie R; Chen X; Cheng L; Huang M; Zhou Q; Zhang J; Chen Y; Peng S; Chen Z; Dong W; Huang J; Lin T
    Mol Ther; 2021 Jan; 29(1):291-307. PubMed ID: 32950106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14.
    Yang ZY; Zhao C; Liu SL; Pan LJ; Zhu YD; Zhao JW; Wang HK; Ye YY; Qiang J; Shi LQ; Mei JW; Xie Y; Gong W; Shu YJ; Dong P; Xiang SS
    Cancer Lett; 2024 Apr; 587():216703. PubMed ID: 38341127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression.
    Li H; Jiao W; Song J; Wang J; Chen G; Li D; Wang X; Bao B; Du X; Cheng Y; Yang C; Tong Q; Zheng L
    J Exp Clin Cancer Res; 2023 Nov; 42(1):313. PubMed ID: 37993881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-binding protein NONO promotes breast cancer proliferation by post-transcriptional regulation of SKP2 and E2F8.
    Iino K; Mitobe Y; Ikeda K; Takayama KI; Suzuki T; Kawabata H; Suzuki Y; Horie-Inoue K; Inoue S
    Cancer Sci; 2020 Jan; 111(1):148-159. PubMed ID: 31733123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
    Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO
    Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
    Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
    Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of NUSAP1 inhibits cell proliferation and invasion through downregulation of TOP2A in human glioblastoma.
    Hu Y; Xue Z; Qiu C; Feng Z; Qi Q; Wang J; Jin W; Zhong Z; Liu X; Li W; Zhang Q; Huang B; Chen A; Wang J; Yang N; Zhou W
    Cell Cycle; 2022 Sep; 21(17):1842-1855. PubMed ID: 35532155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcribed ultraconserved element uc.51 promotes the proliferation and metastasis of breast cancer by stabilizing NONO.
    Shi X; Huang X; Chen R; Li Y; Xu Y; Zhang W; Zhu Q; Zha X; Wang J
    Clin Exp Metastasis; 2021 Dec; 38(6):551-571. PubMed ID: 34714466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine methylation and citrullination of splicing factor proline- and glutamine-rich (SFPQ/PSF) regulates its association with mRNA.
    Snijders AP; Hautbergue GM; Bloom A; Williamson JC; Minshull TC; Phillips HL; Mihaylov SR; Gjerde DT; Hornby DP; Wilson SA; Hurd PJ; Dickman MJ
    RNA; 2015 Mar; 21(3):347-59. PubMed ID: 25605962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSPC1, NONO, and SFPQ are expressed in mouse Sertoli cells and may function as coregulators of androgen receptor-mediated transcription.
    Kuwahara S; Ikei A; Taguchi Y; Tabuchi Y; Fujimoto N; Obinata M; Uesugi S; Kurihara Y
    Biol Reprod; 2006 Sep; 75(3):352-9. PubMed ID: 16641145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circ_0001588 sponges miR-211-5p to facilitate the progression of glioblastoma via up-regulating YY1 expression.
    Wang Q; Zheng D; Li Y; Zhang Y; Sui R; Chen Y; Liang H; Shi J; Pan R; Xu X; Sun D
    J Gene Med; 2021 Oct; 23(10):e3371. PubMed ID: 34105224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of dimerization and nucleic acid binding of human DBHS proteins NONO and PSPC1.
    Knott GJ; Chong YS; Passon DM; Liang XH; Deplazes E; Conte MR; Marshall AC; Lee M; Fox AH; Bond CS
    Nucleic Acids Res; 2022 Jan; 50(1):522-535. PubMed ID: 34904671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic upregulation of NONO and PSPC1 regulates Sertoli cell response to MEHP via modulation of ALDH1A1 signaling.
    Dong BW; Jin XH; Yan CY; Yang T; Cai GQ; Lu J
    FEBS Lett; 2017 Mar; 591(6):914-923. PubMed ID: 28117896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N
    Yang L; Chen Y; Liu N; Shi Q; Han X; Gan W; Li D
    J Hematol Oncol; 2021 Mar; 14(1):46. PubMed ID: 33741027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
    Kim SJ; Ju JS; Kang MH; Eun JW; Kim YH; Raninga PV; Khanna KK; Győrffy B; Pack CG; Han HD; Lee HJ; Gong G; Shin Y; Mills GB; Eyun SI; Park YY
    Theranostics; 2020; 10(18):7974-7992. PubMed ID: 32724453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
    Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
    Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.